Paulo Rafael Cardoso de Sousa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Paulo Rafael Cardoso de Sousa has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Adriano Ferreira Martins
Universidade Federal do Ceará, Brasil
1 shared publication - Carl Kendall
Tulane University
1 shared publication - Carlos Sanhueza-Sanzana
Universidade Federal do Ceará, Brazil
1 shared publication - Clarissa Romero Teixeira
Fundação Oswaldo Cruz, Brasil
1 shared publication - Cristiane Cunha Frota
Universidade Federal do Ceará, Brazil
1 shared publication - Francisco Gustavo Silveira Correia
Universidade Federal do Ceará, Brasil
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Ciencia & Saude Coletiva
- Vol. 31 (6)
Kinetics of IgG-specific antibodies against chikungunya virus in a female cohort study in Brazil, 2018-2019
The kinetics of IgG-specific antibody responses against chikungunya virus (CHIKV) is poorly understood. A total of 559 paired serum samples were collected at baseline and at first follow-up in a cohort of women aged 15-39 years from endemic areas of Fortaleza, Ceará State, following the major 2017 outbreak from February 2018 to August 2019. To estimate longitudinal seroprevalence, combining antibody markers (anti-CHIKV IgM and IgG) were screened by using enzyme-linked immunosorbent assays. We found an overall seroprevalence of 34% (190/559; 95%CI, 30.2-38.0) and 31.3% (175/559; 95%CI, 27.6-35.3) at baseline and first follow-up, respectively. Also, the distribution of seroprevalence did not differ significantly by age group [15-24 years, 35.4% (92/260); 25-39 years, 32.8% (98/299)]. Additionally, we found that median IgG level decreased over time across all age groups, and independent of prior history of symptomatic infection. We also observed four cases of seroreversion. Our findings provided valuable information regarding the decline of anti-CHIKV IgG levels in a post-epidemic scenario, highlighting the importance of serological surveillance to better understand the kinetics of antibody responses and to characterize epidemic risk.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Ciencia & Saude Coletiva
- Vol. 31 (6)
Open AccessKinetics of IgG-specific antibodies against chikungunya virus in a female cohort study in Brazil, 2018-2019
The kinetics of IgG-specific antibody responses against chikungunya virus (CHIKV) is poorly understood. A total of 559 paired serum samples were collected at baseline and at first follow-up in a cohort of women aged 15-39 years from endemic areas of Fortaleza, Ceará State, following the major 2017 outbreak from February 2018 to August 2019. To estimate longitudinal seroprevalence, combining antibody markers (anti-CHIKV IgM and IgG) were screened by using enzyme-linked immunosorbent assays. We found an overall seroprevalence of 34% (190/559; 95%CI, 30.2-38.0) and 31.3% (175/559; 95%CI, 27.6-35.3) at baseline and first follow-up, respectively. Also, the distribution of seroprevalence did not differ significantly by age group [15-24 years, 35.4% (92/260); 25-39 years, 32.8% (98/299)]. Additionally, we found that median IgG level decreased over time across all age groups, and independent of prior history of symptomatic infection. We also observed four cases of seroreversion. Our findings provided valuable information regarding the decline of anti-CHIKV IgG levels in a post-epidemic scenario, highlighting the importance of serological surveillance to better understand the kinetics of antibody responses and to characterize epidemic risk.